FDA Licenses First At-Home Administered Influenza Vaccine
by Carolyn Hendler, JD
The U.S. Food and Drug Administration (FDA) has licensed the first of its kind live attenuated nasal spray influenza vaccine that can ...
U.S. Government Gives Moderna $176 Million to Develop mRNA Bird Flu Biologic
by Amber Baker
On July 2, 2024, the U.S. government awarded a $176 million contract to Moderna, Inc. for the development of an ...
BARDA Awards $9.27 Million Contract to Evaluate Oral Pill COVID Vaccine
by TVR Staff
Biotechnology firm Vaxart, Inc. announced on Jan. 19, 2024 that it received a $9.27 million contract from the U.S. Biomedical ...
Only Remaining HIV Vaccine Efficacy Trial Fails in Africa
by TVR Staff
The latest effort to develop an HIV (human immunodeficiency viruses) vaccine in Uganda, Tanzania and South Africa was halted on ...
Oral Vaccine for COVID Under Development in Japan
by Carolyn Hendler, JD
Researchers in Japan have been working on a new vaccine for COVID-19 that would be administered orally rather than by ...
U.S. Taxpayers Fund $5 Billion Project NextGen to Develop Novel COVID Vaccines and Drugs
by Amber Baker
Just three months after the Biden administration announced that U.S. taxpayers would fund a $5 billion initiative called Project NextGen ...
Novel mRNA Lyme Shots Could Be Released in 2025
by Amber Baker
Two novel messenger RNA (mRNA) shots for Lyme disease currently in late-stage clinical trials could hit the market as early ...
3D Printed Vaccine Skin Patches Being Developed
by Carolyn Hendler, JD
In an attempt to increase consumer demand for COVID-19 shots, researchers have designed a vaccine printer that can print COVID ...
U.S. to Spend Billions on New COVID Vaccines Despite Failure to Prevent Infection
by Amber Baker
The Biden administration announced earlier this month that the U.S. government will spend at least $5 billion on Project NextGen ...
In this section
Latest
Popular
Comments
Latest
Popular
Comments
- Janet on More Serious Side Effects from Ozempic and Wegovy Weight Loss Drugs
- malinda Barker on FDA Licenses First At-Home Administered Influenza Vaccine
- K on Kindergarten Vaccination Rates Decrease as Vaccine Exemptions Increase
- John Riesenman on The PREP Act’s Role in Shielding Big Pharma and Incentivizing Harmful COVID-19 Treatments
- Mary Ann ISAAC on The PREP Act’s Role in Shielding Big Pharma and Incentivizing Harmful COVID-19 Treatments